| 08:30 to 08:55 AM | Trends and outcomes of stem cell transplantation Biju George Christian Medical College Vellore, Vellore, India |
| 08:55 to 09:20 AM | Navigating the equitability barrier of gene editing therapies in India Debojyoti Chakraborty CSIR-Institute of Genomics & Integrative Biology (IGIB), New Delhi, India |
| 09:20 to 09:45 AM | Development of curative therapies for inherited anemias Senthil Bhoopalan St. Jude Children’s Research Hospital, Memphis, TN, USA |
| 09:45 to 10:10 AM | Recent Advances in CAR T-Cell Therapy for Hematologic Malignancies Vikram Mathews Christian Medical College Vellore, Vellore, India |
| 08:30 to 08:55 AM | Understanding Inherited Eye Diseases (IEDs) and Developing Newer Therapeutics Indumathi Mariappan BRIC-Institute for Stem Cell Science and Regenerative Medicine (inStem), Bengaluru, India |
| 08:55 to 09:20 AM | Future Directions in Corneal Regeneration: Convergence of Stem Cell Biology and Biomaterials Vivek Singh L V Prasad Eye Institute, Hyderabad, India. |
| 09:20 to 09:45 AM | Gene Therapy in Retinal Dystrophies: Real-World Effectiveness and Challenges Deepika Parameswarappa Narayana Nethralaya, Bengaluru, India |
| 09:45 to 10:10 AM | A synthetic splice-enhancer intron platform for efficient hybrid dual-AAV gene therapy: application in Stargardt disease Arkasubhra Ghosh Narayana Nethralaya Foundation, Bengaluru, India |
| 10:35 to 11:00 AM | Beyond Insulin: Regenerating Beta Cells via Stem Cell Therapy versus Growth Factors Rohit Kulkarni Harvard Medical School, Boston, MA, USA |
| 11:00 to 11:25 AM | Genetic Forms of Lipodystrophy and Emerging Gene Therapy Strategies Aaron Chapla Christian Medical College Vellore, Vellore, India |
| 11:25 to 11:50 AM | Total Pancreatectomy with Islet Autotransplantation for Chronic Pancreatitis: An International Experience Gopalakrishnan Loganathan Otsuka American Pharmaceuticals, Minnesota, USA |
| 11:50 to 12:15 PM | Understanding targets at single-islet-cells for anti-diabetic treatment Nikhil Gandasi Indian Institute of Science (IISc), Bengaluru, India |
| 10:35 to 11:00 AM | Metadherin-mRNA-LNPs for Triple-Negative Breast Cancer Therapy Srinivasa Reddy Bonam CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad, India |
| 11:00 to 11:25 AM | Engineering Controlled Destabilization: The “Magic Methyl” Effect in RNAi Enhancement Kiran R. Gore Indian Institute of Technology (IIT) Kharagpur, Kharagpur, India |
| 11:25 to 11:50 AM | Biomaterial-based acellular cancer immunotherapy Prakriti Tayalia Indian Institute of Technology (IIT) Bombay, Mumbai, India |
| 11:50 to 12:15 PM | Extracellular vesicles in cancer therapy Suresh Mathivanan La Trobe Institute for Molecular Science, Victoria, Australia |
| 01:30 to 01:55 PM | Leveraging Human iPSC’s to Advance Hypertrophic Cardiomyopathy Treatment John Carter Ralphe University of Wisconsin, Madison, WI, USA |
| 01:55 to 02:20 PM | Organization principles governing the assembly and function of contractile units across scales Minhaj Sirajuddin BRIC-Institute for Stem Cell Science and Regenerative Medicine (inStem), Bengaluru, India |
| 02:20 to 02:45 PM | PRKCA variants cause hypertrophic cardiomyopathy in multi-ancestry patients, stem cell-derived cardiomyocytes, and pre-clinical models through ERK1/2 Dhandapani Perundurai BRIC-Institute for Stem Cell Science and Regenerative Medicine (inStem), Bengaluru, India |
| 02:45 to 03:10 PM | From Prenatal Biomarker to Therapeutic Target: Circular RNA-X in Hypoplastic Left Heart Syndrome Anupam Mittal Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India |
| 01:30 to 01:55 PM | Molecular and Functional characterization of patients with Mucopolysaccharidosis Ashwin Dalal BRIC-Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, India |
| 01:55 to 02:20 PM | Delving for precision care in Gaucher disease Sumita Danda Christian Medical College Vellore, Vellore, India |
| 02:20 to 02:45 PM | Molecular timing and scaling of hepatic gluconeogenic output during fed-fast transitions Ullas Kolthur Seetharaman BRIC-Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, India |
| 02:45 to 03:10 PM | Gene therapy for liver inherited metabolic diseases Julien Baruteau University College London (UCL), Great Ormond Street Institute of Child Health, London, UK |
| 03:10 to 03:35 PM | Beyond Conventional Antiseizure Medications: Small Molecules and Gene Therapies in Childhood Epilepsies Sangeetha Yoganathan Christian Medical College Vellore, Vellore, India |
| 03:35 to 04:00 PM | Next-generation gene therapy for neuromuscular disorders - Opportunities for global impact with indigenous solution. Jayandharan G. Rao Indian Institute of Technology (IIT) Kanpur, Kanpur, India |
| 04:00 to 04:25 PM | Gene therapy for Developmental Epileptic Encephalopathy - from Bench to Bedside Srinivasarao Repudi BRIC-Institute for Stem Cell Science and Regenerative Medicine (inStem), Bengaluru, India |
| 04:25 to 04:50 PM | Niemann–Pick Disease: From Molecular Diagnosis to Therapeutic Frontiers Neerja Gupta All India Institute of Medical Sciences (AIIMS), New Delhi, India |
| 03:10 to 03:35 PM | Decoding Cell-State Transitions Through Enhancer and Chromatin Dynamics Srinivas Animireddy BRIC-Institute for Stem Cell Science and Regenerative Medicine (inStem), Bengaluru, India |
| 03:35 to 04:00 PM | RBM3 mRNA delivery with functionalized lipid nanoparticles for improving muscle function Marepally Srujan Kumar Centre for Stem Cell Research, Christian Medical College Vellore, Vellore, India |
| 04:00 to 04:25 PM | Stem Cell Transplantation in Ischemic Heart: A Cure in Waiting - or a Battle for Survival Sanjay Kumar All India Institute of Medical Sciences (AIIMS), Bathinda, India |
| 04:25 to 04:50 PM | Translational potential of Human Liver organoids for chronic liver diseases: Deliberations From bench to bedside approaches Ruchi Tandon Translational Health Science and Technology Institute, Faridabad, Haryana, India |
| 08:30 to 08:55 AM | Gene therapy for Hemophilia A Aby Abraham Christian Medical College Vellore, Vellore, India |
| 08:55 to 09:20 AM | Targeted base editing enables safe and efficient knockout of ELANE for the treatment of ELANE-associated severe congenital neutropenia Mohankumar Murugesan Centre for Stem Cell Research, Christian Medical College Vellore, Vellore, India |
| 09:20 to 09:45 AM | Precision conditioning for precision medicine: Targeted, Non-Genotoxic hematopoietic stem cell Conditioning to Enable Gene Therapy with Gene-Edited Stem Cells Saravanabhavan Thangavel Centre for Stem Cell Research, Christian Medical College Vellore, Vellore, India |
| 09:45 to 10:10 AM | A pharmacological modulator of Glucocerebrosidase reverses pathogenic phenotypes in Gaucher’s disease and GBA1-Parkinson’s disease Models Sivaprakash K Ramalingam Indian Institute of Technology (IIT) Kanpur, Kanpur, India |
| 08:30 to 08:55 AM | Human Intestinal Organoids as Models of Enteric Infections and Vaccines Sasirekha Ramani Baylor College of Medicine, Houston, TX, USA |
| 08:55 to 09:20 AM | Chromatinopathies, Ciliopathies, and Brain Malformations: From Genetic Mechanisms to Disease Models Bhavana Muralidharan BRIC-Institute for Stem Cell Science and Regenerative Medicine (inStem), Bengaluru, India |
| 09:20 to 09:45 AM | Disease modelling using iPSC Shaji RV Centre for Stem Cell Research, Christian Medical College Vellore, Vellore, India |
| 09:45 to 10:10 AM | Organs in a Dish: Intestinal and Liver Organoids for Human Disease Modelling Vijayalakshmi B Centre for Stem Cell Research, Christian Medical College Vellore, Vellore, India |
| 10:35 to 11:00 AM | In vitro prediction of CAR-T Cell Function, Persistence, and Therapeutic Success Priyadarshini Chatterjee MicroCRISPR Pvt. Ltd, New Delhi, India |
| 11:00 to 11:25 AM | Towards Accessible, Equitable, and Affordable Cell Therapy: The Promise of Allogeneic γδ CAR-T Cells Lakshmikanth S Gandikota Immuneel Therapeutics Private Limited, Bengaluru, India |
| 11:25 to 11:50 AM | Regulatory Aspects of Cell and Gene Therapy: Navigating the Indian Regulatory Pathway Akhil Kumar Journey to West, Singapore |
| 11:50 to 12:15 PM | Allogeneic Off-the-Shelf Natural Killer (NK) Cells for Autoimmune Disorders and Cancers Renjitha Gopurappilly NKure Therapeutics Pvt Ltd, (CCAMP), Bengaluru, India |
| 10:35 to 11:00 AM | Navigating Our Way to Developing Next Generation CAR T Cell Therapy – The XenCART Model Gaurav Kharya Cellogen Therapeutics Pvt. Ltd., Noida, India |
| 11:00 to 11:25 AM | The Evolving Landscape of Mesenchymal Stromal Cell Therapy and Regulatory Considerations Pawan Kumar Gupta Stempeutics, Research Private Ltd., Bengaluru, India |
| 11:25 to 11:50 AM | Real world evidence (RWE) of efficacy and safety of Talicel Rahul Purwar Immunoadoptive Cell Therapy Private Limited (ImmunoACT) & IIT Bombay, Mumbai, India |
| 11:50 to 12:15 PM | A Phase 1/2a Clinical Trial of Allogeneic Retinal Pigmented Epithelium (RPE) cells in Geographic Atrophy (GA): Interim Results of Safety & Efficacy Jogin Desai Eyestem Research Private Ltd., (CCAMP), Bengaluru, India |
| 01:30 to 01:55 PM | The Cell-Gene Therapy Road Beyond B-Cell Malignancies Needs Smarter Strategies and not just Better CARs Gaurav Narula Tata Memorial Centre, Mumbai, India |
| 01:55 to 02:20 PM | Post CART cell therapy - complications Sharat Damodar Mazumdar Shaw Medical Center, Bengaluru, India |
| 02:20 to 02:45 PM | From Donor to Dose: Translating Allogeneic CAR-NK Cell Therapy Towards Clinical Reality Dinesh Kundu East Ocyon Bio, Gurugram, India |
| 02:45 to 03:10 PM | Generation and Preclinical Evaluation of TRAC/B2M Cytosine Base-Edited Allogeneic CD19 CAR-T Cells for B-ALL Thiyagaraj Mayuranathan Centre for Stem Cell Research, Christian Medical College Vellore, Vellore, India |
| 01:30 to 01:55 PM | MicroRNA in Epidermolysis Bullosa—Pathophysiologic and translational Significance Vinod Kumar Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India |
| 01:55 to 02:20 PM | Cell-based therapies from genetic to inflammatory skin disease Su Lwin King's College London (KCL), London, UK |
| 02:20 to 02:45 PM | Engineering Human Skin: Applications of 3D Skin Models in Dermatology Research Archana Singh CSIR-Institute of Genomics & Integrative Biology (IGIB), New Delhi, India |
| 02:45 to 03:10 PM | Accessible Diagnostics & Affordable Therapies for Incurable Genetic Skin Diseases Vamsi K. Yenamandra Sri Madhusudhan Sai Institute of Medical Sciences & Research (SMSIMSR), Chikkaballapur, India |
| 03:10 to 03:30 PM | Addressing ATMP manufacturing Risks through Closed Vial Technologies Shrikant Rao Pharmalab India Pvt. Ltd. (Representing Aseptic Technologies, Belgium) |
| 03:30 to 03:50 PM | Empowering Cell and Gene Therapy: Overcoming Bottlenecks with Innovative Agilent Cell Analysis Solutions Saket Siddharth Agilent Technologies, Hyderabad, India |
| 03:50 to 04:10 PM | Transforming Translational Research with Cell & Gene Therapy and Spatial Biology Solutions Asim Iqbal Shaikh Miltenyi Biotec, India. |
| 04:10 to 04:30 PM | From Process Development to GMP Execution - India's First Versatile Plasmid DNA Manufacturing Platform Bhushan Kantode & Kavya Kannan Kodo Lifescience Pvt. Ltd, Vapi, India |
| 04:30 to 04:50 PM | A Scalable Framework for CRISPR Off-Target Assessment Using Orthogonal Nomination and Targeted Deep Sequencing Edward Wong Serng Yuen Integrated DNA Technologies (IDT), Singapore |
| 04:50 to 05:10 PM | The Cell Therapy Reset: Redefining the Path Forward Through Modular Manufacturing and In Vivo Immune Engineering Vaibhav Daund Cytiva Ltd., India |
| 03:10 to 03:22 PM | Generation of Human Corneal Epithelial Cells from induced Pluripotent Stem Cells in Serum-Free and Feeder-Free Conditions using a Chemically Defined Medium Vikram Krishna L V Prasad Eye Institute, India, India |
| 03:22 to 03:34 PM | Targeting IFITM2/3 to Enhance Lentiviral Transduction Efficiency in CD34+ Hematopoietic Stem and Progenitor Cells Shreejha Chandrasekar Shankara Cancer Hospital and Research Institute, India |
| 03:34 to 03:46 PM | Characterization and In Vitro Evaluation of the Regenerative Potential of Pooled Human Bone Marrow-Derived Mesenchymal Stromal Cell-Conditioned Medium for Diabetic Foot Ulcers Neema V Shetty Manipal Academy of Higher Education (MAHE), India |
| 03:46 to 03:58 PM | Developing Novel Immunotherapy Strategies for Treating Relapsed, CD20/CD19-Negative Diffuse Large B-Cell Lymphoma (DLBCL) Nandini Sharma Advanced Center for Treatment, Research, and Education in Cancer (ACTREC), India |
| 03:58 to 04:10 PM | Characterization of Paracrine and Neuroprotective Response of RPE Cells Under Oxidative and Cellular Stress Recapitulating AMD-Like Disease Conditions Nikshitha Ramanath Manipal Academy of Higher Education (MAHE), India |
| 04:10 to 04:22 PM | Cell-Penetrating Peptide-Based Gene Delivery for Potential Therapy of Autosomal Recessive Congenital Ichthyosis. Idrees Qadir Gojree CSIR Institute of Genomics and Integrative Biology, India |
| 04:22 to 04:34 PM | One-Time CRISPR Adenine Base Editing Intervention in SMA: From SMN2 Splice Correction to Motor Neuron Rescue Sheena P Kochumon Amrita Institute of Medical Sciences and Research Centre, India |
| 04:34 to 04:46 PM | Metabolically Optimized, CD19-Targeted Allogeneic CAR-T Cells Overcome Antigen Escape and Show Persistent Killing in B-Cell Malignancies Riya Agarwal MicroCrispr Pvt. Ltd., India |
| 04:46 to 04:58 PM | In Vitro Proof-of-Concept Evaluation of GD2-Specific CAR-Engineered Allogeneic γδ T Cells Against Solid Tumors Hascitha J Immuneel therapeutics Pvt. Ltd., India |
| 04:58 to 05:10 PM | Investigating ABI1 as a new cardiomyopathy gene using multi-ancestry patient-exomes, base-edited iPSCs and Knock-in mice models Saptashwa Chakrabarti BRIC-Institute for Stem Cell Science and Regenerative Medicine (inStem), India. |